MANNITOL 10% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mannitol 10% In Plastic Container, and when can generic versions of Mannitol 10% In Plastic Container launch?
Mannitol 10% In Plastic Container is a drug marketed by B Braun and Icu Medical Inc and is included in two NDAs.
The generic ingredient in MANNITOL 10% IN PLASTIC CONTAINER is mannitol. There are eighteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the mannitol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MANNITOL 10% IN PLASTIC CONTAINER?
- What are the global sales for MANNITOL 10% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for MANNITOL 10% IN PLASTIC CONTAINER?
Summary for MANNITOL 10% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 164 |
Clinical Trials: | 225 |
DailyMed Link: | MANNITOL 10% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for MANNITOL 10% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Hospital, Geneva | Phase 3 |
Morten Hostrup, PhD | N/A |
Centre Hospitalier Universitaire Vaudois | Early Phase 1 |
Pharmacology for MANNITOL 10% IN PLASTIC CONTAINER
Drug Class | Osmotic Diuretic |
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Diuresis |
US Patents and Regulatory Information for MANNITOL 10% IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun | MANNITOL 10% IN PLASTIC CONTAINER | mannitol | INJECTABLE;INJECTION | 020006-002 | Jul 26, 1993 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Icu Medical Inc | MANNITOL 10% IN PLASTIC CONTAINER | mannitol | INJECTABLE;INJECTION | 019603-002 | Jan 8, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for MANNITOL 10% IN PLASTIC CONTAINER
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Pharmaxis Europe Limited | Bronchitol | mannitol | EMEA/H/C/001252 Bronchitol is indicated for the treatment of cystic fibrosis (CF) in adults aged 18 years and above as an add-on therapy to best standard of care. |
Authorised | no | no | no | 2012-04-13 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |